Wednesday, November 15, 2017

Lyme class-action lawsuit filed by 28 Lyme patients

It's about time for something like this!


[news] Insurers Accused of Conspiring to Deny Lyme Disease Coverage 
Wed Nov 15, 2017 1:11 pm (PST) .  
*Insurers Accused of Conspiring to Deny Lyme Disease Coverage *

By Cameron Langford, /Courthouse News Service/, Pasadena, California

November 14, 2017

TEXARKANA, Texas (CN) – Twenty-eight people claim in a federal antitrust 
lawsuit that Lyme disease victims are being forced to pay hundreds of 
thousands of dollars for treatment because health insurers are denying 
coverage with bogus guidelines established by their paid consultants, 
who falsely say the disease can always be cured with a month of antibiotics.

Suffering from migraine headaches, an irregular heartbeat, hearing 
problems and nerve pain, lead plaintiff Lisa Torrey says in the lawsuit 
filed Friday in Texarkana, Texas federal court that she visited 36 
doctors, some of whom misdiagnosed her with multiple sclerosis and 
fibromyalgia and said her symptoms were all in her head, before she was 
properly diagnosed with Lyme disease.

*Full story*:

*Contact /Court//h//ouse News Service/*: <>

The mission of LymeInfo is to keep you informed of issues that might be of interest to Lyme disease patients.   Postings are not meant to imply that we agree with the content of all items we distribute.

For Lyme information, see:

Please tell others how to subscribe to this group:

Monday, November 6, 2017

Tick Paralysis in British Columbia


Tick paralysis results from exposure to a neurotoxin released by tick salivary glands during a blood meal; it is the only tick-borne disease not caused by an infectious agent. The toxin appears to be produced exclusively by female, egg-laden ticks. It is most commonly seen in children under 16, and within this population affects girls more than boys, probably because ticks are harder to detect under longer hair. Among adults, men are disproportionately affected.
Worldwide, over 40 tick species have been associated with tick paralysis, but in North America the most common culprits are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick). Bites from Amblyomma and Ixodes ticks can also cause tick paralysis. In the United States, tick paralysis is most common in the Pacific Northwest, Rocky Mountain states and southeastern part of the country. It occurs most frequently in the spring months, from April through June.

(Since ticks often carry more than one infectious microbe, a person could also contract other diseases along with Tick paralysis)

From 1993 to 2016, there were 56 cases of suspected tick paralysis with at least one tick specimen submitted for testing at the BCCDC PHL. Humans and animals were involved in 43% and 57% of cases, respectively. The majority of cases involved a Dermacentor andersoni tick (48 cases or 86%) and occurred between the months of April and June (49 cases or 88%). Among known locations of tick acquisition, the Interior region of BC was disproportionately affected, with 25 cases (69%) of tick bites occurring in that area.

Wednesday, October 25, 2017

New Lyme book from Columbia University seems promising

Here is an announcement from Publishers Weekly:

Conquering Lyme Disease: Science Bridges the Great Divide
Brian A. Fallon and Jennifer Sotsky. Columbia Univ., $30 (384p) ISBN 978-0-231-18384-0
Fallon and Sotsky, the director of the Lyme and Tick-Borne Diseases Research Center and a psychiatry resident at Columbia University Medical Center, respectively, assemble a sturdy reference on an illness whose varied presentations can bedevil patients and caregivers alike. The authors candidly warn of the technical density of much of their material. The first four chapters on Lyme's early history, signs and symptoms, and diagnostics, as well as a later chapter on treatment options, will be well over the heads of most laypersons. The authors zero in on the unsettling effects that medical uncertainties have on patients and their families, lavishing praise on those who've "played a pivotal role in shaping our understanding" of the disease that has led to better insurance coverage and funding. The authors also hail new discoveries and "the biotechnology revolution" in diagnosing and treating Lyme, offering practical advice and resources for disease prevention and transmission. Perhaps most poignant is their analysis of the daunting experience of being a Lyme patient. But there's hope, too: "Medical professionals are gradually waking up to the complexity of Lyme disease and to the real suffering of patients with chronic symptoms." Aimed at specialists, Fallon and Sotsky's heady volume presents the multidisciplinary cadre aiming to restore Lyme patients "to their former well-being and good grace." (Dec.)

Please note that the proceeds of the book will go to Lyme Research at Columbia...

Ordering directly from Columbia University Press provides a nice discount.

Tuesday, October 24, 2017

NAC reduces Parkinson’s disease symptoms and protects brain

If you are having trouble viewing this email, click here.
You are receiving this mailing because you are subscribed to Awakening From Alzheimer's

A safe, widely available antioxidant nutrient is now being recognized as a brain-protector that can both defend your brain against the damage of a concussion and help improve your brain if you get Parkinson's disease.

Those are two remarkable characteristics for a single, natural nutrient.

But don't wait till you get a bang on the head or you're diagnosed with Parkinson's. Those in the know about this inexpensive supplement have long understood that it can help the brain produce more glutathione – the body and brain's most powerful, important antioxidant.

In fact, in Peggy's interview with Dr. Jay Faber of the Amen Clinic, he specifically mentioned the importance of this nutrient.

And now this substance, n-acetylcysteine – known more popularly as NAC – has been shown in research at Thomas Jefferson University in Philadelphia to be especially beneficial in managing Parkinson's disease – and dementia.

NAC Boosts Glutathione

Perhaps the most serious consequence of Parkinson's is the way the condition interferes with the brain's release of dopamine – a crucial neurotransmitter. Because of this and other brain changes that occur in Parkinson's, you begin to lose your ability to move around on your own. Worse, you have a 50/50 risk of losing your memory and succumbing to dementia within ten years of your diagnosis.1

More than a thousand Americans are diagnosed with Parkinson's every day.2

About the only way conventional medicine has been able to help these patients is to temporarily replace the missing dopamine in the brain. This is done using a combination of drugs, but the drugs are only effective for a limited amount of time. Eventually, they don't work anymore.

The good news is that our understanding of this disease is getting better. Studies in the past few years have shown that oxidative stress from free radicals plays a part in its development – and the oxidative stress contributes to glutathione depletion.

That's where NAC comes in – research now demonstrates that NAC may reverse this glutathione reduction and help protect neurons.

In the Thomas Jefferson study, researchers analyzed how Parkinson's patients' physical condition and mental abilities improved while taking NAC, and also used brain imaging to trace how the brain's levels of dopamine responded.3

The results were striking.

"This study reveals a potentially new avenue for managing Parkinson's patients and shows that n-acetylcysteine may have a unique physiological effect that alters the disease process and enables dopamine neurons to recover some function,""says researcher Daniel Monti.

Better Recovery from Brain Injuries

The other recent impressive discovery about NAC: it helps the brain recover from a concussion.

Researchers at the Case Western Reserve University School of Medicine in Cleveland have demonstrated that NAC has unique benefits for brain tissue when taken immediately after a concussive blow to the head.4

About 1.7 million Americans suffer concussions every year – in car accidents, falls, sports collisions and other mishaps. The Centers for Disease Control and Prevention calls these injuries – TBIs (traumatic brain injuries) – a "silent epidemic." Right now, more than three million people live with memory problems and other long term mental difficulties because they've suffered blows to the head.

But NAC can help limit this damage – a fact that's also been demonstrated in tests on military personnel in the Middle East who have suffered TBIs.5

This type of action is the reason that David W. Dodick, a professor of neurology at the Mayo Clinic, says that in case a child receives a head injury at a sporting event – "Every coach and parent could be carrying this on the sidelines."

I don't know if this finding has been accepted by the wider medical community. Probably not. It's new and (horrors!) it's nutritional.

But I don't view NAC as some kind of emergency medicine. Nearly every adult over 40 can use more glutathione. 

Indeed, this super-antioxidant is one of the secrets of long life. Our own bodies make it, but with age, the average person makes less and less, and by the time we're in our sixties most of us are severely deficient.

You can read a full report on this from our sister company, Green Valley Natural Solutions. They offer a glutathione-boosting supplement that contains a clinical dose of NAC plus a whole passel of other nutrients that can add years to your life.

Kind regards,

Lee Euler

PS: To read more about NAC and how it can work with other nutrients to boost and restore your glutathione levels, I encourage you to click here to learn more from our sister company about the research they've been doing in this area.








Awakening from Alzheimer's | PO Box 1076 Lexington, VA 24450 

Friday, October 20, 2017

Dr. Jane Marke on the psychiatric manifestations of Lyme disease

 Dr. Jane Marke on the psychiatric manifestations of Lyme disease

Is it Lyme or mental illness? According to this psychiatrist, sometimes it's both. Watch her presentation to the Central Mass Lyme Foundation's conference.


Friday, October 6, 2017

Budget laboratory for Lyme testing

As you probably know if you have been treating Lyme disease for a while, the testing to attempt to determine whether or not you have Lyme disease and/or coinfections can be very expensive. I saw this today from a listserv I am on, where clinicians talk to each other and answer questions about Lyme and other infections. I have not heard of these labs before so I can't make recommendations, but it sounds as though they would be worth checking out.


Medical Diagnostics Laboratories in NJ does quite a few antibodies and PCR's.  They have a package price for self-pay patients and it does not matter how many tests you order.  the price is $225.

Pathogenius labs in TX (now MicroGen) does well on non-tickborne bacteria.  They do any body fluid EXCEPT blood, as far as I know.  They do DNA sequencing for 25,000 organisms.  We have had positive results from them on various fluids.  You might want to check them out online. I think the price was around $250-$300, quite reasonable.

Saturday, September 30, 2017

The everything test?!

This came to my attention today. I don't know anything about it, yet. I'm asking around. If you discover anything please let me know. 


Aperiomics is the only company identifying every bacteria, virus, parasite, and fungus in one test. We specialize in identifying the unknown.

Wednesday, September 6, 2017

Reaching a Consensus in Lyme Disease
Panelists Peter L. Salgo, MD; Robert C. Bransfield, MD, DLFAPA; Leonard Sigal, MD; Samuel Shor, MD, FACP; and Patricia V. Smith share their thoughts on what needs to happen before a consensus can be reached in Lyme disease. 

Saturday, September 2, 2017

Monkeys with Parkinson's disease benefit from human stem cells:

Great news for people with Parkinson's disease!

Transplantation of neurons made from induced pluripotent stem cells show long-term benefit in monkeys with Parkinson's disease -- ScienceDaily